- febuxostat hemihydrate
POM: Prescription only medicine
Summary: In a phase IV clinical study (the CARES study) in patients with gout and a history of major CV disease, a significant higher risk of all-cause mortality and for CV-related death was observed in patients treated with febuxostat compared to those treated with allopurinol. Treatment with febuxostat in patients with pre-existing major CV disease should be avoided, unless no other therapy options are appropriate.
For Healthcare Professionals
6 Riverview Road, Beverley, Hull, HU17 0LD
+44 (0)1482 860228
+44 (0)1748 828873
+44 (0)1482 389858